Literature DB >> 20497275

Towards a compatible probiotic-antibiotic combination therapy: assessment of antimicrobial resistance in the Japanese probiotics.

A M Hammad1, T Shimamoto.   

Abstract

AIM: To determine the antimicrobial resistance of the Japanese probiotics available in the market without a pharmacist's supervision. METHODS AND
RESULTS: A total of 43 isolates were obtained from 40 samples of probiotics (30 dairy products and 10 products in tablet form). Isolates were identified using 16S rRNA gene sequencing and tested for their susceptibility to 14 antimicrobials. They were screened using PCR for some antibiotic resistance genes. Inactivation of cefepime, clarithromycin and vancomycin by different inocula of 11 strains was evaluated using the antibiotic inactivation bioassay. None of the dairy probiotics showed a level of constitutive resistance or carried inducible resistance genes, making them suitable to be administrated with macrolides. Among the probiotics in tablet form only Enterococcus faecium strains carrying the msrC gene showed an MIC(90) of 4 μg ml(-1). Extended-spectrum β-lactams, tetracyclines and ampicillin exhibited powerful germicidal activity against the vast majority of the probiotic strains.
CONCLUSIONS: There is a limited choice of the Japanese probiotics that can be administered with clinically used antibiotics. SIGNIFICANCE AND IMPACT OF THE STUDY: Japanese probiotics are widely distributed all over the world. Through the findings of our study, we have attempted to provide guidance for clinicians interested in using the Japanese probiotics in combination with antibiotics.
© 2010 The Authors. Journal compilation © 2010 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497275     DOI: 10.1111/j.1365-2672.2010.04762.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  9 in total

1.  Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella Typhimurium: a possible adjunct therapy.

Authors:  Praveen Rishi; Simran Preet; Prabhjot Kaur
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-02-27       Impact factor: 3.944

2.  Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC).

Authors:  Geert Huys; Nadine Botteldoorn; Frank Delvigne; Luc De Vuyst; Marc Heyndrickx; Bruno Pot; Jean-Jacques Dubois; Georges Daube
Journal:  Mol Nutr Food Res       Date:  2013-06-25       Impact factor: 5.914

Review 3.  Addressing the Antibiotic Resistance Problem with Probiotics: Reducing the Risk of Its Double-Edged Sword Effect.

Authors:  Ivan C V J Imperial; Joyce A Ibana
Journal:  Front Microbiol       Date:  2016-12-15       Impact factor: 5.640

4.  Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs.

Authors:  Dhanashree Lokesh; Raman Parkesh; Rajagopal Kammara
Journal:  Sci Rep       Date:  2018-08-09       Impact factor: 4.379

5.  Protective Effect of Potential Probiotic Strains from Fermented Ethiopian Food against Salmonella Typhimurium DT104 in Mice.

Authors:  Guesh Mulaw; Diriba Muleta; Anteneh Tesfaye; Tesfaye Sisay
Journal:  Int J Microbiol       Date:  2020-04-13

6.  Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota.

Authors:  Si-Lan Gu; Yiwen Gong; Jiaying Zhang; Yunbo Chen; Zhengjie Wu; Qiaomai Xu; Yunhui Fang; Jingxia Wang; Ling-Ling Tang
Journal:  Infect Drug Resist       Date:  2020-12-21       Impact factor: 4.003

7.  In vitro evaluation of anti-infective activity of a Lactobacillus plantarum strain against Salmonella enterica serovar Enteritidis.

Authors:  Jugal Kishore Das; Debasmita Mishra; Pratikshya Ray; Prangya Tripathy; Tushar K Beuria; Neera Singh; Mrutyunjay Suar
Journal:  Gut Pathog       Date:  2013-05-13       Impact factor: 4.181

8.  Characterization and anti-salmonella activities of lactic acid bacteria isolated from cattle faeces.

Authors:  Adewale Adetoye; Eric Pinloche; Bolanle A Adeniyi; Funmilola A Ayeni
Journal:  BMC Microbiol       Date:  2018-08-30       Impact factor: 3.605

9.  Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina®, and insights into its probiotic properties.

Authors:  Indu Khatri; Gaurav Sharma; Srikrishna Subramanian
Journal:  BMC Microbiol       Date:  2019-12-30       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.